Manoj Chawla

Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial

Leili Gao, Byung‐Wan Lee, Manoj Chawla et al. · Nature Medicine · 2023 · 95 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the <scp>VIRTUE</scp> study

Monira Alarouj, Ahmed Hassoun, R. Medlej et al. · International Journal of Clinical Practice · 2013 · 67 citations · Full text

Medicine, Endocrinology, Pharmacology +11

Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial

Mala Dharmalingam, S. R. Aravind, Hemant Thacker et al. · Drugs · 2020 · 52 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India

Ping Rao, B. M. Makkar, Ajay Kumar et al. · International Journal of Diabetes in Developing Countries · 2018 · 33 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region

Lee‐Ling Lim, Eric S. H. Lau, Amy Fu et al. · JAMA Network Open · 2021 · 33 citations · Full text

Medicine, Health Informatics, Health Sciences +17